Aigen Investment Management, LP Invitae Corp Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $25,297 - $53,406	14,794 New	14,794 $27,000
Q1 2022 May 05, 2022	SELL	$6.28 - $15.59 $176,725 - $438,718	-28,141 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $294,205 - $573,801	20,014 Added 246.27%	28,141 $451,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $197,567 - $273,067	8,127 New	8,127 $231,000
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $259,244 - $380,676	-6,632 Closed	0 $0

Q3 2020 Nov 06, 2020	BUY	$28.43 - $44.67 $188,547 - $296,251	6,632 New	6,632 $287,000
Q1 2020 May 08, 2020	SELL	$7.64 - $27.5 $694,743 - $2.5 Million	-90,935 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$15.02 - $20.57 $1.37 Million - $1.87 Million	90,935 New	90,935 $1.47 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.